Form D Explorer
Trellis Bioscience, Inc. · CIK 1162015

Report a data issueCitable research briefCompare issuerPrivate research collection

Trellis Bioscience, Inc.

CIK 1162015 · Corporation · Inc. DELAWARE · Redwood City, California · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The Oct 29, 2026 filing reports $9,093,000 sold, but the offering amount is unavailable as a number. From May 15, 2026 to Oct 29, 2026, the explorer stores 5 original notices and 1 amendments.

Filings
6
Original notices
5
Amendments
1
Activity
May 15, 2026
through Oct 29, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldOct 21, 2026 · DOct 29, 2026 · D/ALater minus earlier
Reported offering amount———
Reported amount sold$22,892,056$9,093,000$-13,799,056
Reported investor count8816-72
Reported minimum investment$0$0$0

Earlier SEC source: 0000929638-26-003976 · Later SEC source: 0000929638-26-004073

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Oct 29, 2026

Reported offering amount
—
Reported exemptions
Rule 506(b)
Reported amount sold
$9,093,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Shared EDGAR submitting account

These filings share an external submitting CIK in their accession numbers. The account may belong to a filing agent. How EDGAR assigns accession numbers.

Form D filings (6)